DANIEL MUSHER to Immunoglobulin G
This is a "connection" page, showing publications DANIEL MUSHER has written about Immunoglobulin G.
Connection Strength
1.969
-
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Hum Vaccin. 2011 Sep; 7(9):919-28.
Score: 0.308
-
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis. 2010 Feb 15; 201(4):516-24.
Score: 0.277
-
Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Clin Infect Dis. 2001 Feb 15; 32(4):534-8.
Score: 0.148
-
IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides. Clin Infect Dis. 1998 Dec; 27(6):1487-90.
Score: 0.127
-
Acute Febrile Illness and Complications Due to Murine Typhus, Texas, USA1,2. Emerg Infect Dis. 2017 08; 23(8):1268-1273.
Score: 0.116
-
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med. 1997 Feb; 45(2):57-68.
Score: 0.112
-
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
Score: 0.107
-
The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis. 1996 Jan; 22(1):165-7.
Score: 0.104
-
Pneumococcal vaccination for patients with spinal cord injury. Arch Phys Med Rehabil. 1993 Dec; 74(12):1354-7.
Score: 0.090
-
Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990 Apr; 161(4):728-35.
Score: 0.070
-
Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis. 1990 Apr; 161(4):736-40.
Score: 0.070
-
Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis. 2005 Apr 01; 191(7):1063-7.
Score: 0.049
-
Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis. 2001 Mar 01; 183(5):827-30.
Score: 0.037
-
Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis. 2001 Jan 15; 32(2):307-10.
Score: 0.037
-
Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis. 2000 Jan; 30(1):25-8.
Score: 0.034
-
Aberrant secondary antibody responses to sheep erythrocytes in rabbits with experimental syphilis. Infect Immun. 1979 Jul; 25(1):133-8.
Score: 0.033
-
Altered immune responsiveness associated with experimental syphilis in the rabbit: elevated IgM and depressed IgG responses to sheep erythrocytes. J Immunol. 1978 May; 120(5):1691-5.
Score: 0.031
-
Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides. Infect Immun. 1996 Jul; 64(7):2457-66.
Score: 0.027
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul; 17(1):66-73.
Score: 0.022
-
Evidence that autologous idiotypic regulation of anti-arginine-glycine-aspartic acid autoantibodies may influence development and progression of syphilitic lesions in infected rabbits. Infect Immun. 1992 Sep; 60(9):3861-71.
Score: 0.021
-
IgG antibody reactive with five serotypes of Streptococcus pneumoniae in commercial intravenous immunoglobulin preparations. J Infect Dis. 1992 Jul; 166(1):38-42.
Score: 0.020
-
V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons. Clin Vaccine Immunol. 2011 Mar; 18(3):362-6.
Score: 0.018
-
Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun. 1990 Dec; 58(12):3871-6.
Score: 0.018
-
Immunoglobulin class and subclass restriction of autoimmune responses in secondary syphilis. Clin Exp Immunol. 1990 Jun; 80(3):381-6.
Score: 0.018
-
Ig class and IgG subclass responses to Treponema pallidum in patients with syphilis. J Clin Immunol. 1988 Mar; 8(2):128-39.
Score: 0.015
-
Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection. J Clin Microbiol. 1986 Mar; 23(3):411-5.
Score: 0.013
-
Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J Immunol. 1986 Feb 15; 136(4):1406-14.
Score: 0.013
-
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis. 2003 Aug 01; 37(3):438-47.
Score: 0.011
-
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis. 1999 Aug; 29(2):281-8.
Score: 0.008
-
Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med. 1998 Feb 16; 187(4):631-40.
Score: 0.008
-
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
Score: 0.006